Publications by authors named "Zhengbin Zhu"

Objective: The aim of this study was to investigate the relationship between circulating levels of B cell activating factor (BAFF) and the presence and severity of coronary artery disease (CAD) and acute myocardial infarction (AMI) in humans, as its biological functions in this context remain unclear.

Methods: Serum BAFF levels were measured in a cohort of 723 patients undergoing angiography, including 204 patients without CAD (control group), 220 patients with stable CAD (CAD group), and 299 patients with AMI (AMI group). Logistic regression analyses were used to assess the association between BAFF and CAD or AMI.

View Article and Find Full Text PDF
Article Synopsis
  • The study investigates the use of Ga-labelled fibroblast activation protein inhibitor-04 (Ga-FAPI-04) PET/MR imaging to evaluate myocardial fibrosis in STEMI patients.
  • It includes 33 patients, with findings showing that those who experienced worsening renal function (WRF) had higher Ga-FAPI-04 uptake, indicating a potential link between myocardial fibroblast activation and kidney health.
  • Ga-FAPI-04 uptake at baseline is identified as a predictor for WRF, suggesting that this imaging technique could provide valuable insights into renal function post-STEMI.
View Article and Find Full Text PDF

In high-risk patients with pure native aortic regurgitation (PNAR), transcatheter aortic valve replacement (TAVR) remains an off-label intervention. Due to anatomical variations in the aortic root and technical challenges unique to PNAR, the transfemoral approach (TF-TAVR) requires continued accumulation of experience and technological refinement. In this context, we successfully and safely performed a snare-assisted TF-TAVR procedure for a patient with PNAR, characterized by significant aortic angulation.

View Article and Find Full Text PDF
Article Synopsis
  • Obstructive sleep apnea (OSA) is linked to increased risk of ST-segment elevation myocardial infarction (STEMI) during the night, with this study examining the timing and frequency of STEMI occurrences in OSA patients compared to non-OSA patients.
  • In a study of 397 patients, 33% of those with OSA experienced STEMI onset between midnight and 5:59 am, significantly higher than the 15% in non-OSA patients, indicating a nearly threefold increased risk of STEMI during these hours for OSA patients.
  • Over a follow-up period of nearly three years, STEMI onset times in OSA patients were associated with a heightened risk of adverse cardiovascular and cerebrovascular events
View Article and Find Full Text PDF
Article Synopsis
  • The study investigated left ventricular remodeling (LVR) in patients with acute STEMI who were treated with primary percutaneous coronary intervention (PCI), focusing on the connection between early left ventricular dilation and later LVR outcomes.
  • Out of 301 patients, 18.9% experienced LVR, with significant differences in left ventricular end-diastolic volume (LVEDV) changes between those with LVR and those without during follow-up.
  • Early measurement of changes in LVEDV after discharge and at 1 month was effective in predicting late LVR at the 6-month mark, suggesting that consistent monitoring may improve patient outcomes.
View Article and Find Full Text PDF

Background: Chronic kidney disease (CKD) accelerates atherosclerosis, but the mechanisms remain unclear. Tyrosine sulfation has been recognized as a key post-translational modification (PTM) in regulation of various cellular processes, and the sulfated adhesion molecules and chemokine receptors have been shown to participate in the pathogenesis of atherosclerosis via enhancement of monocyte/macrophage function. The levels of inorganic sulfate, the essential substrate for the sulfation reaction, are dramatically increased in patients with CKD, which indicates a change of sulfation status in CKD patients.

View Article and Find Full Text PDF

Objectives: The B cell activating factor (BAFF) is a B cell survival factor involved in atherosclerosis and ischemia-reperfusion (IR) injury. This study sought to investigate whether BAFF is a potential predictor of poor outcomes in patients with ST-segment elevation myocardial infarction (STEMI).

Methods: We prospectively enrolled 299 patients with STEMI, and serum levels of BAFF were measured.

View Article and Find Full Text PDF
Article Synopsis
  • * Out of 847 patients, those who achieved optimal LDL-C levels (below 1.4 mmol/L and a reduction of at least 50% from baseline) showed a significantly lower rate of NTL plaque progression compared to those in the non-optimal group.
  • * Both univariate and multivariate logistic regression analyses identified achieving the recommended LDL-C levels as an independent protective factor against NTL plaque progression, suggesting that managing LDL-C effectively may reduce future cardiac events.
View Article and Find Full Text PDF
Article Synopsis
  • The study aimed to evaluate the effectiveness of [Ga]Ga-DOTA-FAPI-04 PET/MR imaging in predicting late left ventricular (LV) remodeling in patients who experienced a ST-segment elevation myocardial infarction (STEMI).
  • Twenty-six STEMI patients underwent [Ga]Ga-DOTA-FAPI-04 PET/MR scans at the start and about 12 months later, looking for an increase in LV end-systolic volume (LVESV) as a marker of LV remodeling.
  • Results showed that higher baseline uptake of [Ga]Ga-DOTA-FAPI-04 was linked to an increased risk of LV remodeling, with this imaging technique proving more predictive than conventional clinical assessments and imaging methods.
View Article and Find Full Text PDF

Chronic kidney disease (CKD) accelerates atherosclerosis. The mechanism of CKD-related atherosclerosis is complex, and CKD-specific risk factors may contribute to this process in addition to traditional risk factors such as hypertension, diabetes, and hypercholesterolemia. In the present study, to discover CKD-specific atherosclerosis risk factors, a total of 62 patients with different stages of kidney function were enrolled.

View Article and Find Full Text PDF

Background: This is first-in-man investigation of an implantable Heartech left ventricular partitioning device (LVPD) therapy for chronic heart failure (HF) after a myocardial infarction.

Methods And Results: Initially, 16 patients were chosen from 3 cardiac centers within China. All patients were treated with percutaneous ventricular restoration involving the Heartech LVPD implantation.

View Article and Find Full Text PDF

Motion estimation is a fundamental step in dynamic medical image processing for the assessment of target organ anatomy and function. However, existing image-based motion estimation methods, which optimize the motion field by evaluating the local image similarity, are prone to produce implausible estimation, especially in the presence of large motion. In addition, the correct anatomical topology is difficult to be preserved as the image global context is not well incorporated into motion estimation.

View Article and Find Full Text PDF

Background: Investigating the prognostic value of the Murray law-based quantitative flow ratio (μQFR) on the clinical outcome after treatment of in-stent restenosis (ISR) with a drug-coated balloon (DCB).

Methods: Patients participating in a previous randomized clinical trial for DCB-ISR were post-hoc analyzed. The primary endpoint was vessel-oriented composite endpoint (VOCE), defined as cardiac death, target vessel-related myocardial infarction, and ischemia-driven target vessel revascularization.

View Article and Find Full Text PDF

Myocardial infarction (MI) is one of the leading causes of morbidity and mortality worldwide. The immune response plays a central role in post-MI cardiac repair. A growing body of evidence suggests that oncostatin M (OSM), a pleiomorphic cytokine of the interleukin (IL)-6 family, participates in the cardiac healing and remodeling process.

View Article and Find Full Text PDF

Automated segmentation of left ventricular cavity (LVC) in temporal cardiac image sequences (consisting of multiple time-points) is a fundamental requirement for quantitative analysis of cardiac structural and functional changes. Deep learning methods for segmentation are the state-of-the-art in performance; however, these methods are generally formulated to work on a single time-point, and thus disregard the complementary information available from the temporal image sequences that can aid in segmentation accuracy and consistency across the time-points. In particular, single time-point segmentation methods perform poorly in segmenting the end-systole (ES) phase image in the cardiac sequence, where the left ventricle deforms to the smallest irregular shape, and the boundary between the blood chamber and the myocardium becomes inconspicuous and ambiguous.

View Article and Find Full Text PDF

Although the drug-eluting stent (DES) has become the standard for percutaneous coronary intervention (PCI)-based revascularization, concerns remain regarding the use of DES, mainly due to its permanent rigid constraint to vessels. A drug-eluting bioresorbable stent (BRS) was thus developed as an alternative to DES, which can be absorbed entirely after its therapeutic period. Magnesium (Mg)-based BRSs have attracted a great deal of attention due to their suitable mechanical properties, innovative chemical features, and well-proven biocompatibility.

View Article and Find Full Text PDF

Background: Sulfation of tyrosine, yielding O-sulfotyrosine, is a common but fixed post-translational modification in eukaryotes. Patients with increased circulating O-sulfotyrosine levels experience a faster decline in renal function with progression to end-stage renal disease (ESRD). In the present study, we measured serum O-sulfotyrosine levels in individuals with chronic kidney disease (CKD) and acute kidney injury (AKI) to explore its ability to differentiate AKI from CKD.

View Article and Find Full Text PDF

Background: Chronic kidney disease (CKD) is associated with an increased risk of the progression of coronary artery disease (CAD). However, there are few data on the relationship between CAD severity and the duration of CKD. This study assessed the predictive value of the duration of kidney dysfunction in CKD patients with CAD severity.

View Article and Find Full Text PDF

Objectives: This study presents 1-year follow-up data of echocardiographic outcomes in patients who received the Heartech® left ventricular (LV) partitioning device (LVPD) (Xinrui Medical Equipment Co. Ltd., Shanghai, China).

View Article and Find Full Text PDF

Mitsugumin 53 or Tripartite motif 72 (MG53/TRIM72), a myokine/cardiokine belonging to the tripartite motif family, can protect the heart from ischemic injury and regulate lipid metabolism in rodents. However, its biological function in humans remains unclear. This study sought to investigate the relationship between circulating MG53 levels and coronary artery disease (CAD).

View Article and Find Full Text PDF

Background: Treatment of coronary in-stent restenosis (ISR) remains challenging in contemporary clinical applications. Drug-coated balloon (DCB) angioplasty offers an effective treatment for ISR. Shenqi is a novel iopromide-based paclitaxel-coated balloon and its clinical safety, effectiveness and angiographic efficacy in patients with ISR have not been investigated.

View Article and Find Full Text PDF

Mitsugumin 53 (MG53), a muscle-specific protein belonging to the TRIM family, has been demonstrated to protect the heart against oxidative injury. Although previous studies indicated that ischemic hearts released MG53 into circulation in mice, its effects in humans remains unknown. We aimed to evaluate the prognostic value of MG53 in patients with ST-segment elevation myocardial infarction (STEMI).

View Article and Find Full Text PDF

Rationale: Macrophages are critically involved in wound healing following myocardial infarction (MI). Lgr4, a member of LGR (leucine-rich repeat-containing G protein-coupled receptor) family, is emerging as a regulator of macrophage-associated immune responses. However, the contribution of Lgr4 to macrophage phenotype and function in the context of MI remains unclear.

View Article and Find Full Text PDF

Background: Diabetes mellitus (DM) plays an important role in restenosis and late in-stent thrombosis (ST). The current study using optical coherence tomography (OCT) aims to compare target lesion neointima in patients with or without diabetes after zotarolimus-eluting stent (ZES) treatment.

Methods: OCT images of 90,212 struts and quantitative coronary angiography (QCA) in 62 patients (32 with DM and 30 without DM) with 69 de novo coronary lesions (34 DM and 35 non-DM) both after ZES implantation and 12 ± 1 month angiographic follow-up were recorded.

View Article and Find Full Text PDF

Purpose: The purpose of this study was to investigate the relationship between serum levels of lipoprotein lipase (LPL), hepatic lipase (HL), and endothelial lipase (EL) and the progression of coronary artery disease (CAD).

Materials And Methods: According to the inclusion criteria, exclusion criteria, diagnostic criteria, angiography results, and the random matching scheme, the enrolled patients were divided into the following two groups: the progression-free group (n = 47) and the progression group (n = 15). The baseline characteristics and various biochemical parameters were obtained from the medical records and medical history.

View Article and Find Full Text PDF